We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
MISGUIDED PANIC AND MISSED OPPORTUNITY FOR PHARMACEUTICAL INVENTIONS: HOW UNEXPECTED RESULTS ECLIPSED REASONABLE EXPECTATION OF SUCCESS IN BMS V. TEVA.
- Authors
Pride, Christelle K.
- Abstract
The article focuses on the decision of the U.S. Court of Appeals for the Federal Circuit in the case Bristol-Myers Squibb Co. v. Teva Pharmaceuticals U.S.A, Inc. regarding the assessment of the reasonable expectation of success of pharmaceutical and chemical inventions. It mentions that the Court held that Bristol-Myers Squibb's patent for Entecavir, a drug used to treat chronic hepatitis B, was invalid and Bristol-Myers and Teva Pharmaceuticals alleging patent infringement.
- Subjects
UNITED States; BRISTOL-Myers Squibb Co.; TEVA Pharmaceuticals USA Inc.; PATENT invalidation; PATENT law; PATENT infringement; ACTIONS &; defenses (Law)
- Publication
Berkeley Technology Law Journal, 2016, Vol 31, p587
- ISSN
1086-3818
- Publication type
Article
- DOI
10.15779/Z38C85X